NextCure, Inc. (NXTC) Misses Q3 EPS by 277c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($3.22), $2.77 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Gordon Haskett cuts TJX Companies rating to Accumulate
• Robo.ai completes acquisitions, plans interim report for Aug. 24
• The Campbell's Co. (CPB) PT Raised to $18 at UBS